Streetbeat News

SMMNY

Siemens Healthineers AG

https://www.siemens-healthineers.com/

CEO

Bernhard Montag

Industry

Surgical and Medical Instrument Manufacturing

Open

27.33

Mkt cap

61B

Volume

2.6K

High

27.34

P/E Ratio

30.28

52-wk high

31.73

Low

27.25

Div yield

0.02

52-wk low

25.54

Profound Medical Corp. and Siemens Healthineers have partnered to offer a comprehensive MRI-guided prostate therapy solution, combining Profound's TULSA-PRO system with Siemens' Magnetom Free.Max scanner. This collaboration aligns with the CMS 2025 Final Rule for Urology APC Level 7 reimbursement.

Portfolio Pulse from

December 02, 2024 | 12:45 pm

Siemens Healthineers has faced recent underperformance due to below-expectations revenue, mixed margins, and lower fiscal 2025 guidance. However, strong performance in imaging and radiation oncology, along with long-term growth prospects in these areas, supports a positive outlook.

Portfolio Pulse from

November 26, 2024 | 6:30 pm

The article discusses Siemens Healthineers as a promising investment in the Medtech sector ahead of its Q4 2024 earnings report. The author plans to increase their stake in the company, indicating a positive outlook.

Portfolio Pulse from

November 05, 2024 | 12:30 pm

Morgan Stanley analyst Patrick Wood initiated coverage on GE HealthCare Technologies Inc (GEHC) with an Equal-Weight rating and a price target of $76. The analyst noted strong Q1 trends across the board for GEHC and its peers, including Abbott Laboratories (ABT), Koninklijke Philips N.V. (PHG), Siemens Healthineers AG (SMMNY), and Intuitive Surgical Inc (ISRG). The analyst sees potential upside for GEHC due to solid demand, sensible margin targets, and a shift in CT technology towards photon counting.

Portfolio Pulse from Shivani Kumaresan

June 27, 2023 | 6:25 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.